Shared Decision-Making in Rheumatoid Arthritis Care
Elena Myasoedova, MD, PhD
Beyond the Black Box: JAK Inhibitor Safety in RA
Roy Fleischmann, MD, MACR
Choosing a JAK Inhibitor for Rheumatoid Arthritis
IFNα Is Associated with a Distinct Immune Endotype in Sjögren’s Disease
What's Next for Sjögren's Disease Treatment?
Nancy Carteron, MD
The Spectrum of Neurologic Conditions in Sjögren's Patients
Understanding Fatigue in Sjögren's Disease
Recognizing Loss of Treatment Response in Psoriatic Arthritis
Philip Mease, MD, MACR
How Delayed Diagnosis Can Affect Psoriatic Arthritis Patients
Improving Psoriatic Arthritis Diagnosis: The Role of Education
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Emerging Therapeutic Approaches for Psoriatic Arthritis
SGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
Targeting Celastrol Delivery to Inflamed Joints in Rheumatoid Arthritis
How Obesity Influences Psoriatic Arthritis Risk and Outcomes
Advancing Bone Health: Key Insights from ISO 2026
Marshall Miller
Ami R. Patel
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.